Quantcast

Daily Traders Edge

Sage Therapeutics stock rockets 73% on hopes for breakthrough depression drug

December 07
19:37 2017

Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.

Continue Reading At MarketWatch

Related Articles

Newsletter Signup

Sign up for our free newsletter